Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 469-475, March 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bresnick, E.
Right arrow Articles by Mossé, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bresnick, E.
Right arrow Articles by Mossé, H.

Rates of Turnover of Deoxythymidine Kinase and of Its Template RNA in Regenerating and Control Liver1

Edward Bresnick, S. S. Williams and H. Mossé

Department of Pharmacology, Baylor University College of Medicine, Houston, Texas 77025

Deoxythymidine kinase levels in liver were maximally enhanced by 12-fold at 24 hr after partial hepatectomy while aspartate transcarbamylase reached maximum activity by 48 hr. The rates of turnover of deoxythymidine kinase and of its template RNA were studied with the use of cycloheximide and actinomycin D, respectively.

The half-life (t1/2) of the template RNA for deoxythymidine kinase in 24-hour regenerating and control adult liver was 7.5 and 3.0 hours, respectively. The t1/2 for aspartate transcarbamylase template RNA was >24 hours in both regenerating and control adult liver.

The rates of turnover of deoxythymidine kinase in regenerating and control livers were determined; the t1/2 was 3.7 and 26 hr, respectively.

It is concluded that immediately following partial hepatectomy, a substance is elaborated which may prolong the life of the deoxythymidine kinase messenger RNA by inactivating a catabolic mechanism and in this manner may ultimately lead to a greater intracellular concentration of enzyme.

1 Supported by grants from the USPHS, National Cancer Institute (CA06571), and the National Science Foundation (GB4339).

Received 7/18/66. Accepted 10/ 7/66.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.